Sale!

SCA-23 Spinocerebellar Ataxia PDYN Gene Mutation Test Cost

Original price was: 1,430 د.إ.Current price is: 1,290 د.إ.

-10%

The “SCA-23 Spinocerebellar Ataxia PDYN Gene Mutation Test” is a specialized genetic test designed to detect mutations in the PDYN gene, which are associated with Spinocerebellar Ataxia Type 23 (SCA-23). SCA-23 is a rare, neurodegenerative disorder characterized by progressive coordination problems, gait abnormalities, and other cerebellar symptoms. Early and accurate diagnosis through genetic testing is crucial for managing symptoms, planning treatment, and providing genetic counseling.

The test involves analyzing the patient’s DNA to identify mutations in the PDYN gene that are known to cause SCA-23. This is crucial for confirming the diagnosis, differentiating SCA-23 from other types of ataxias, and assisting in the clinical management of the condition.

Offered at DNA Labs UAE, the test cost is set at 1290 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing and counseling, ensuring reliable results and comprehensive support for patients and their families.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCA-23 SPINOCEREBELLAR ATAXIA PDYN GENE MUTATION Test

Test Name: SCA-23 SPINOCEREBELLAR ATAXIA PDYN GENE MUTATION Test

Components: PDYN Gene

Price: 1290.0 AED

Sample Condition: 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery: Sample Tue by 11 am; Report Sat

Method: PCR, Sequencing

Test type: Neurologic Disorder-Ataxia

Doctor: Neurologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details

SCA-23, also known as Spinocerebellar Ataxia type 23, is a rare genetic disorder characterized by progressive degeneration of the cerebellum, resulting in impaired coordination and balance. It is caused by mutations in the PDYN gene.

To diagnose SCA-23, a genetic test is performed to identify mutations in the PDYN gene. This test involves obtaining a sample of the individual’s DNA, usually through a blood sample or saliva sample. The DNA is then analyzed to identify any mutations or changes in the PDYN gene sequence.

Genetic testing for SCA-23 can help confirm a diagnosis in individuals showing symptoms of ataxia and determine if they carry the PDYN gene mutation. It can also be used for predictive testing in individuals with a family history of SCA-23 to determine if they have inherited the mutation.

It is important to note that SCA-23 is a rare condition, and genetic testing for this specific gene mutation may not be readily available in all healthcare settings. A consultation with a genetic counselor or a neurologist specializing in ataxias can help guide individuals in obtaining the appropriate testing and diagnosis.

Test Name SCA-23 SPINOCEREBELLAR ATAXIA PDYN GENE MUTATION Test
Components *PDYN Gene
Price 1290.0 AED
Sample Condition 4 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery Sample Tue by 11 am; Report Sat
Method PCR, Sequencing
Test type Neurologic Disorder-Ataxia
Doctor Neurologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

SCA-23, also known as Spinocerebellar Ataxia type 23, is a rare genetic disorder characterized by progressive degeneration of the cerebellum, resulting in impaired coordination and balance. It is caused by mutations in the PDYN gene.

To diagnose SCA-23, a genetic test is performed to identify mutations in the PDYN gene. This test involves obtaining a sample of the individual’s DNA, usually through a blood sample or saliva sample. The DNA is then analyzed to identify any mutations or changes in the PDYN gene sequence.

Genetic testing for SCA-23 can help confirm a diagnosis in individuals showing symptoms of ataxia and determine if they carry the PDYN gene mutation. It can also be used for predictive testing in individuals with a family history of SCA-23 to determine if they have inherited the mutation.

It is important to note that SCA-23 is a rare condition, and genetic testing for this specific gene mutation may not be readily available in all healthcare settings. A consultation with a genetic counselor or a neurologist specializing in ataxias can help guide individuals in obtaining the appropriate testing and diagnosis.